Cargando…

Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening

Hand, foot and mouth disease (HFMD) is a common pediatric illness mainly caused by infection with enterovirus 71 (EV71) and coxsackievirus A16 (CA16). The frequent HFMD outbreaks have become a serious public health problem. Currently, no vaccine or antiviral drug for EV71/CA16 infections has been ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Lin, Su, Weiheng, Jin, Jun, Chen, Jiawen, Li, Xiaojun, Zhang, Xuyuan, Sun, Meiyan, Sun, Shiyang, Fan, Peihu, An, Dong, Zhang, Huafei, Zhang, Xiguang, Kong, Wei, Ma, Tonghui, Jiang, Chunlai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113793/ https://www.ncbi.nlm.nih.gov/pubmed/25036464 http://dx.doi.org/10.3390/v6072778

Ejemplares similares

Identification of a Common Epitope between Enterovirus 71 and Human MED25 Proteins Which May Explain Virus-Associated Neurological Disease
por: Fan, Peihu, et al.
Publicado: (2015)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China
por: Ji, Hong, et al.
Publicado: (2012)

Bioinformatics-based prediction of conformational epitopes for Enterovirus A71 and Coxsackievirus A16
por: Wang, Liping, et al.
Publicado: (2021)

Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China
por: Wang, Jian-xing, et al.
Publicado: (2016)

Immunologic Characterization of Cytokine Responses to Enterovirus 71 and Coxsackievirus A16 Infection in Children
por: Zhang, Shu-Yan, et al.
Publicado: (2015)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China
por: Li, Wei, et al.
Publicado: (2013)

Antiviral Ability of Kalanchoe gracilis Leaf Extract against Enterovirus 71 and Coxsackievirus A16
por: Wang, Ching-Ying, et al.
Publicado: (2012)

Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China
por: CHEN, LING, et al.
Publicado: (2012)

Novel Substituted Heteroaromatic Piperazine and Piperidine Derivatives as Inhibitors of Human Enterovirus 71 and Coxsackievirus A16
por: Zhang, Xian, et al.
Publicado: (2013)

A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil
por: Yi, Eun-Je, et al.
Publicado: (2023)

Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010
por: Ang, Li Wei, et al.
Publicado: (2015)

Transcriptome analysis following enterovirus 71 and coxsackievirus A16 infection in respiratory epithelial cells
por: Song, Jie, et al.
Publicado: (2020)

Computational Screening of Newly Designed Compounds against Coxsackievirus A16 and Enterovirus A71
por: Sripattaraphan, Amita, et al.
Publicado: (2022)

Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2
por: Li, Xiaojun, et al.
Publicado: (2013)

Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
por: Perera, David, et al.
Publicado: (2004)

VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
por: Chen, Fang-Hong, et al.
Publicado: (2019)

Characterization of human enterovirus71 virus-like particles used for vaccine antigens
por: Zhao, Dandan, et al.
Publicado: (2017)

Systematic Identification and Bioinformatic Analysis of MicroRNAs in Response to Infections of Coxsackievirus A16 and Enterovirus 71
por: Zhu, Zheng, et al.
Publicado: (2016)

Seroprevalence of Human Enterovirus 71 and Coxsackievirus A16 in Guangdong, China, in Pre- and Post-2010 HFMD Epidemic Period
por: Li, Wei, et al.
Publicado: (2013)

Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection
por: Chan, Yoke-Fun, et al.
Publicado: (2005)

Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s
por: Li, Yuyun, et al.
Publicado: (2011)

Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice
por: Dai, Wenwen, et al.
Publicado: (2019)

Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China
por: Cai, Kang, et al.
Publicado: (2019)

Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice
por: Zhao, Hui, et al.
Publicado: (2015)

Chlorogenic Acid Inhibits the Replication and Viability of Enterovirus 71 In Vitro
por: Li, Xiang, et al.
Publicado: (2013)

Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16
por: Thao, Nguyen Thi Thanh, et al.
Publicado: (2010)

Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16
por: Kelly, James T., et al.
Publicado: (2015)

Development of stable, cold-adapted, temperature-sensitive/conditional lethal chimeric enterovirus A71 and coxsackievirus A16
por: Chua, Kaw Bing, et al.
Publicado: (2022)

Molecular evolutionary dynamics of enterovirus A71, coxsackievirus A16 and coxsackievirus A6 causing hand, foot and mouth disease in Thailand, 2000–2022
por: Noisumdaeng, Pirom, et al.
Publicado: (2023)

Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease
por: Wang, Jingjing, et al.
Publicado: (2013)

Evaluation of human enterovirus 71 and coxsackievirus A16 specific immunoglobulin M antibodies for diagnosis of hand-foot-and-mouth disease
por: Yu, Nan, et al.
Publicado: (2012)

Serum MicroRNA Expression Profile Distinguishes Enterovirus 71 and Coxsackievirus 16 Infections in Patients with Hand-Foot-and-Mouth Disease
por: Cui, Lunbiao, et al.
Publicado: (2011)

Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand
por: Lerdsamran, Hatairat, et al.
Publicado: (2018)

Eupafolin and Ethyl Acetate Fraction of Kalanchoe gracilis Stem Extract Show Potent Antiviral Activities against Enterovirus 71 and Coxsackievirus A16
por: Wang, Ching-Ying, et al.
Publicado: (2013)

Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response
por: Wang, Yan, et al.
Publicado: (2018)

Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3
por: Song, Jae-Hyoung, et al.
Publicado: (2014)

Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017
por: Kamau, Everlyn, et al.
Publicado: (2021)

Estimation of Basic Reproduction Number of Enterovirus 71, Coxsackievirus A6 and A16 in Hand, Foot, and Mouth Disease Outbreaks in Singapore
por: Lim, Cindy, et al.
Publicado: (2014)

Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice
por: Caine, Elizabeth A., et al.
Publicado: (2015)

Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade
por: Noisumdaeng, Pirom, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qd7aes0n3vfes165b2c79pl98j